CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

被引:0
作者
Madadi, Parvaz [1 ]
Amstutz, Ursula [2 ,3 ,4 ]
Rieder, Michael [5 ,6 ,7 ]
Ito, Shinya [1 ]
Fung, Vincent [8 ,9 ,10 ,11 ]
Hwang, Soomi [3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Turgeon, Jacques [12 ,13 ]
Michaud, Veronique [12 ,13 ]
Koren, Gideon [1 ,5 ,6 ,7 ]
Carleton, Bruce C. [2 ,3 ,4 ]
机构
[1] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Dept Pediat, Toronto, ON, Canada
[2] Univ British Columbia, Div Translat Therapeut, Dept Pediat, Vancouver, BC, Canada
[3] BC Childrens Hosp, Pharmaceut Outcomes Programme, Vancouver, BC, Canada
[4] Child & Family Res Inst, Vancouver, BC, Canada
[5] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, Clin Pharmacol, London, ON, Canada
[6] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada
[7] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pediat, London, ON, Canada
[8] Prohlth Clin Res Ctr, Vancouver, BC, Canada
[9] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[10] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada
[11] Univ British Columbia, Fac Med, Dept Pathol & Lab Med, Vancouver, BC, Canada
[12] Ctr Hosp Univ Montreal, Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Montreal, PQ, Canada
[13] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
来源
JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY | 2013年 / 20卷 / 03期
基金
加拿大健康研究院;
关键词
Codeine; morphine; pharmacogenetics; CYP2D6; guidelines;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This guideline is intended to provide a basis for informed decision-making regarding genetic testing to identify those individuals who will not benefit from codeine therapy, as well as those who are at an increased risk for codeine-induced toxicity. This guideline addresses the following key questions: 1) Should genetic testing for CYP2D6 be performed in patients prior to the initiation of codeine therapy? 2) How should patients with an indication for codeine therapy be managed based on their genotyping results for CYP2D6?
引用
收藏
页码:E369 / E396
页数:28
相关论文
共 52 条
  • [1] Ontogeny of dextromethorphan O- and N-demethylation in the first year of life
    Blake, M. J.
    Gaedigk, A.
    Pearce, R. E.
    Bomgaars, L. R.
    Christensen, M. L.
    Stowe, C.
    James, L. P.
    Wilson, J. T.
    Kearns, G. L.
    Leeder, J. S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) : 510 - 516
  • [2] The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis
    Brousseau, David C.
    McCarver, D. Gail
    Drendel, Amy L.
    Divakaran, Karthika
    Panepinto, Julie A.
    [J]. JOURNAL OF PEDIATRICS, 2007, 150 (06) : 623 - 626
  • [3] AGREE II: advancing guideline development, reporting and evaluation in health care
    Brouwers, Melissa C.
    Kho, Michelle E.
    Browman, George P.
    Burgers, Jako S.
    Cluzeau, Francoise
    Feder, Gene
    Fervers, Beatrice
    Graham, Ian D.
    Grimshaw, Jeremy
    Hanna, Steven E.
    Littlejohns, Peter
    Makarski, Julie
    Zitzelsberger, Louise
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) : E839 - E842
  • [4] Caraco Y, 1996, DRUG METAB DISPOS, V24, P761
  • [5] Caraco Y, 1996, J PHARMACOL EXP THER, V278, P1165
  • [6] DISPOSITION AND METABOLISM OF CODEINE AFTER SINGLE AND CHRONIC DOSES IN ONE POOR AND 7 EXTENSIVE METABOLIZERS
    CHEN, ZR
    SOMOGYI, AA
    REYNOLDS, G
    BOCHNER, F
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 381 - 390
  • [7] Codeine, Ultrarapid-Metabolism Genotype, and Postoperative Death
    Ciszkowski, Catherine
    Madadi, Parvaz
    Phillips, Michael S.
    Lauwers, Albert E.
    Koren, Gideon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08) : 827 - 828
  • [8] Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine
    Dalen, P
    Frengell, C
    Dahl, ML
    Sjoqvist, F
    [J]. THERAPEUTIC DRUG MONITORING, 1997, 19 (05) : 543 - 544
  • [9] Glucuronidation in humans - Pharmacogenetic and developmental aspects
    de Wildt, SN
    Kearns, GL
    Leeder, JS
    van den Anker, JN
    [J]. CLINICAL PHARMACOKINETICS, 1999, 36 (06) : 439 - 452
  • [10] Derry S, 2010, COCHRANE DATABASE SY